Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerba Path is a specialized network of anatomocytopathology experts and a key division of the Cerba HealthCare group. The company provides advanced diagnostic services, leveraging digital pathology, Next-Generation Sequencing (NGS), and artificial intelligence to support personalized medicine and therapeutic decision-making. With a focus on oncology and complex diseases, Cerba Path operates multiple technical platforms across France and Belgium, processing over one million digitized slides annually. Its services are integrated into the broader Cerba HealthCare ecosystem, providing clinicians with high-precision diagnostic data and expert pathological interpretation. The network emphasizes innovation through its digital pathology infrastructure, which allows for real-time collaboration among experts and rapid diagnostic turnaround.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerba Path.